{"id":"NCT01755767","sponsor":"Daiichi Sankyo","briefTitle":"Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy","officialTitle":"A Phase 3, Randomized, Double-Blind Study of Tivantinib (ARQ 197) in Subjects With MET Diagnostic-High Inoperable Hepatocellular Carcinoma Treated With One Prior Systemic Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-12-27","primaryCompletion":"2017-03-28","completion":"2017-07-31","firstPosted":"2012-12-24","resultsPosted":"2020-07-15","lastUpdate":"2021-04-06"},"enrollment":383,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Hepatocellular Carcinoma"],"interventions":[{"type":"DRUG","name":"Tivantinib","otherNames":["ARQ197"]},{"type":"DRUG","name":"Placebo","otherNames":["Placebo comparator"]}],"arms":[{"label":"Tivantinib 240 mg BID Cohort","type":"EXPERIMENTAL"},{"label":"Tivantinib 120 mg BID Cohort","type":"EXPERIMENTAL"},{"label":"Placebo Matching 240 mg BID Cohort","type":"PLACEBO_COMPARATOR"},{"label":"Placebo Matching 120 mg BID Cohort","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine if tivantinib (ARQ 197) is effective in treating patients with MET diagnostic-high hepatocellular carcinoma (liver cancer) who have already been treated once with another therapy.","primaryOutcome":{"measure":"Median Overall Survival (OS) Following Treatment With Tivantinib 120 mg BID Compared to Placebo Group in Participants With MET Diagnostic-High Inoperable Hepatocellular Carcinoma (HCC) Treated With One Prior Systemic Therapy","timeFrame":"within 36 months","effectByArm":[{"arm":"Tivantinib 120 mg BID Cohort","deltaMin":8.4,"sd":null},{"arm":"Placebo Matching 120 mg BID Cohort","deltaMin":9.1,"sd":null}],"pValues":[{"comp":"OG000","p":"0.8006"},{"comp":"OG000 vs OG001","p":"0.8061"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":14},"locations":{"siteCount":112,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Canada","France","Germany","Italy","Netherlands","New Zealand","Portugal","Spain","Sweden","Switzerland"]},"refs":{"pmids":["29625879"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":17,"n":28},"commonTop":["Fatigue","Abdominal pain","Ascites","Asthenia","Oedema peripheral"]}}